174 related articles for article (PubMed ID: 17633479)
41. Disruption of Igfbp1 fails to rescue the phenotype of Sirt1-/- mice.
Boily G; He XH; Jardine K; McBurney MW
Exp Cell Res; 2010 Aug; 316(13):2189-93. PubMed ID: 20412791
[TBL] [Abstract][Full Text] [Related]
42. Calorie restriction increases life span: a molecular mechanism.
Wolf G
Nutr Rev; 2006 Feb; 64(2 Pt 1):89-92. PubMed ID: 16536186
[TBL] [Abstract][Full Text] [Related]
43. Comparative deacetylase activity of wild type and mutants of SIRT1.
Malik R; Kashyap A; Bansal K; Sharma P; Rayasam GV; Davis JA; Bora RS; Ray A; Saini KS
Biochem Biophys Res Commun; 2010 Jan; 391(1):739-43. PubMed ID: 19944070
[TBL] [Abstract][Full Text] [Related]
44. Sirt1: Role Under the Condition of Ischemia/Hypoxia.
Meng X; Tan J; Li M; Song S; Miao Y; Zhang Q
Cell Mol Neurobiol; 2017 Jan; 37(1):17-28. PubMed ID: 26971525
[TBL] [Abstract][Full Text] [Related]
45. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor.
Cohen-Kfir E; Artsi H; Levin A; Abramowitz E; Bajayo A; Gurt I; Zhong L; D'Urso A; Toiber D; Mostoslavsky R; Dresner-Pollak R
Endocrinology; 2011 Dec; 152(12):4514-24. PubMed ID: 21952235
[TBL] [Abstract][Full Text] [Related]
46. SIRT1 deacetylase activity and the maintenance of protein homeostasis in response to stress: an overview.
Monteiro JP; Cano MI
Protein Pept Lett; 2011 Feb; 18(2):167-73. PubMed ID: 21121893
[TBL] [Abstract][Full Text] [Related]
47. SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice.
Seifert EL; Caron AZ; Morin K; Coulombe J; He XH; Jardine K; Dewar-Darch D; Boekelheide K; Harper ME; McBurney MW
FASEB J; 2012 Feb; 26(2):555-66. PubMed ID: 22006156
[TBL] [Abstract][Full Text] [Related]
48. [Neuroprotective role of silent information regulator 1 in Alzheimer's disease].
Yang XR; Wang R; Qin HP; Zhao X; Liu NH; Zhang C
Sheng Li Xue Bao; 2011 Aug; 63(4):396-400. PubMed ID: 21861060
[TBL] [Abstract][Full Text] [Related]
49. Caloric restriction, SIRT1 and longevity.
Cantó C; Auwerx J
Trends Endocrinol Metab; 2009 Sep; 20(7):325-31. PubMed ID: 19713122
[TBL] [Abstract][Full Text] [Related]
50. SIRT1: roles in aging and cancer.
Kim EJ; Um SJ
BMB Rep; 2008 Nov; 41(11):751-6. PubMed ID: 19017485
[TBL] [Abstract][Full Text] [Related]
51. [Updated roles of SIRT1 in prostate diseases].
Ma ZM; Tian YJ; Wang ZP; Zhai ZX
Zhonghua Nan Ke Xue; 2016 Apr; 22(4):356-60. PubMed ID: 30088710
[TBL] [Abstract][Full Text] [Related]
52. Calorie restriction upregulated sirtuin 1 by attenuating its ubiquitin degradation in cancer cells.
Han L; Zhao G; Wang H; Tong T; Chen J
Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):165-8. PubMed ID: 24471483
[TBL] [Abstract][Full Text] [Related]
53. A novel c.-274C>G polymorphism in bovine SIRT1 gene contributes to diminished promoter activity and is associated with increased body size.
Li MX; Sun XM; Zhang LZ; Wang J; Huang YZ; Sun YJ; Hu SR; Lan XY; Lei CZ; Chen H
Anim Genet; 2013 Aug; 44(5):584-7. PubMed ID: 23647079
[TBL] [Abstract][Full Text] [Related]
54. Molecular Links between Caloric Restriction and Sir2/SIRT1 Activation.
Wang Y
Diabetes Metab J; 2014 Oct; 38(5):321-9. PubMed ID: 25349818
[TBL] [Abstract][Full Text] [Related]
55. Controlling SIRT1 expression by microRNAs in health and metabolic disease.
Lee J; Kemper JK
Aging (Albany NY); 2010 Aug; 2(8):527-34. PubMed ID: 20689156
[TBL] [Abstract][Full Text] [Related]
56. SIRT1 modulation as a novel approach to the treatment of diseases of aging.
Blum CA; Ellis JL; Loh C; Ng PY; Perni RB; Stein RL
J Med Chem; 2011 Jan; 54(2):417-32. PubMed ID: 21080630
[No Abstract] [Full Text] [Related]
57. SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice.
Mercken EM; Hu J; Krzysik-Walker S; Wei M; Li Y; McBurney MW; de Cabo R; Longo VD
Aging Cell; 2014 Feb; 13(1):193-6. PubMed ID: 23941528
[TBL] [Abstract][Full Text] [Related]
58. The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology.
Wang J; Fivecoat H; Ho L; Pan Y; Ling E; Pasinetti GM
Biochim Biophys Acta; 2010 Aug; 1804(8):1690-4. PubMed ID: 19945548
[TBL] [Abstract][Full Text] [Related]
59. Potential role of sirtuin as a therapeutic target for neurodegenerative diseases.
Han SH
J Clin Neurol; 2009 Sep; 5(3):120-5. PubMed ID: 19826562
[TBL] [Abstract][Full Text] [Related]
60. Sirtuin 1: A Target for Kidney Diseases.
Kong L; Wu H; Zhou W; Luo M; Tan Y; Miao L; Cai L
Mol Med; 2015 Jan; 21(1):87-97. PubMed ID: 25587857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
